News

orange__line
Last Patient Last Visit for Interim Analysis in PHERGain Study

A new milestone of PHERGain study-Chemotherapy-free trastuzumab and pertuzumab in HER2-positive breast cancer: FDG-PET response-adapted strategy-has been achieved...
READ MORE...
Liquid biopsy and ctDNA: the winner tandem

Precision medicine is an approach to patient care that allows doctors to select treatments that are most likely to help patients based on a genetic understanding of their disease. Recent advances in science...
READ MORE...
50% Recruitment Achieved in BARBICAN Study

A new milestone achieved in BARBICAN Study! 20 Spanish patients have been successfully randomized in the study, reaching 50% recruitment in Spain. The last patient to be randomized by Dr. Stradella...
READ MORE...
ESMO Congress 2019 Highlights

The MedSIR Project Development team attended the 2019 annual meeting of the European Society of Molecular Oncology. ESMO is one of the most important professional organizations for medical oncology in the world...
READ MORE...
PARSIFAL Study Status

We are thrilled to announce that follow-up of patients participating in PARSIFAL study has been extended one year in order to meet the study efficacy criteria. End of study was initially planned at the end of 2018. This is a randomized, multicentre...
READ MORE...
PALMIRA study Poster Presentation at ESMO 2019 Congress

The abstract of PALMIRA study was presented in a Poster Display Session at the ESMO 2019 Congress in Barcelona, Spain. PALMIRA poster was presented on Sunday...
READ MORE...
MedSIR at ESMO 2019

The European Society for Medical Oncology (ESMO), founded in 1975, aims at advancing medical oncology on a pan-European basis. ESMO is the leading professional organization for medical oncology, with the overarching goal...
READ MORE...
Publication of TRASTYVERE Clinical Trial

A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2 positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the TRASTYVERE...
READ MORE...
WCLC 2019 Highlights

>From September 7th to September 10th, MedSIR attended the 20th World Conference of Lung Cancer (WCLC), organized by the International Association for the Study of Lung Cancer (IASLC). This year’s edition of the world’s largest international...
READ MORE...